Drawing for BIOVECTOR

USPTO serial 75339348

BIOVECTOR

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MANDIR, FREDERICK
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with BIOVECTOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ANDREW P BRIDGES

ANDREW P BRIDGES WILSON SONSINI GOODRICH & ROSATI PC650 PAGE MILL RDPALO ALTO, CA 94304-1050UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001chemicals for use in the manufacture of pharmaceutical productsACTIVE—
005pharmaceutical preparations, namely, drug delivery systems, drug carriers, pharmaceutical excipients, drug adjuvants, drug activators and drug penetration enhancers; and pharmaceutical preparations used for; neurology, pain, cancer, immunotherapy, vaccines, namely, DNA vaccines, automimmune disease, hormono-therapy, endocrinology, anti-infectious, cardiology, deficiency disease, rheumatology, allergy, otorhino-laryngology, pneumology, ophthalmology, gene therapy and diagnosticsACTIVE—
042pharmaceutical research and development services for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jun 25, 2002ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 16, 2001CNCFCONTINUATION OF FINAL REFUSAL MAILED—
Jun 21, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 18, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 15, 2000EXPREX PARTE APPEAL-REFUSAL REVERSED—
Apr 24, 2000CNESEXAMINERS STATEMENT MAILED—
Jan 3, 2000EXPIEX PARTE APPEAL-INSTITUTED—
Sep 29, 1999DOCKASSIGNED TO EXAMINER—
Jun 14, 1999CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 4, 1999DOCKASSIGNED TO EXAMINER—
Feb 24, 1999REINREINSTATED—
Nov 18, 1998CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 26, 1998ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 30, 1998CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 1998DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance